BlackBarn Capital Partners
BlackBarn Capital Partners reported 18 stocks worth $510M in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are AZUL (30.6%), PRVA (9.4%) and ROIV (9.4%). Compared with Q2 2026, the fund opened new positions in NXT, TMO and CSW, added to AZUL, PRVA and NXPI, trimmed ROIV, DHC and MH and sold out of NIQ, UNH and AMRX.
Latest filing: what BlackBarn Capital Partners did in Q3 2026
vs Q2 2026Dollar changes use the share change at the quarter end price. New and sold out show the whole position.
Portfolio at a glance
share of reported value · Q3 2026Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 | ![]() AZUL Azul Sa-Spon ADR | $156M | 30.6% | 17.3M | +15.7M (+930%) | 2 of 8 | |
| 2 | ![]() PRVA Privia Health Group Inc | $48.1M | 9.4% | 1.9M | +285K (+18%) | 8 of 8 | |
| 3 | ![]() ROIV Roivant Sciences Ltd | $47.8M | 9.4% | 1.4M | −650K (−33%) | 8 of 8 | |
| 4 | ![]() DHC Diversified Healthcare TR | $37.2M | 7.3% | 4M | −75K (−2%) | 8 of 8 | |
| 5 | ![]() NXT Nextracker Inc | $31.3M | 6.2% | 263K | New position | 4 of 8 | |
| 6 | ![]() NXPI Nxp Semiconductors N V | $29.8M | 5.8% | 106K | +16K (+18%) | 3 of 8 | |
| 7 | ![]() NEE Nextera Energy Inc | $29.4M | 5.8% | 335K | No change | 6 of 8 | |
| 8 | ![]() TMO Thermo Fisher Scientific Inc | $22.6M | 4.4% | 45K | New position | 1 of 8 | |
| 9 | ![]() MH McGraw Hill Inc | $21.5M | 4.2% | 2.3M | −175K (−7%) | 5 of 8 | |
| 10 | ![]() VKTX Viking Therapeutics Inc | $20.3M | 4.0% | 520K | −80K (−13%) | 6 of 8 |
Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q2 2026, gone in Q3 2026Options
valued at the underlying shares| Stock | Type | Value | Shares | Change |
|---|---|---|---|---|
![]() SPY Spdr S&P 500 ETF TR | Put | $448M | 600K | −200,000 |
![]() HYG Ishares TR | Put | $80M | 1M | +1,000,000 |
![]() HUM Humana Inc | Put | $39.7M | 100K | +100,000 |
![]() LLY Eli Lilly & Co | Put | $30M | 25K | +25,000 |
![]() OSCR Oscar Health Inc | Put | $28.5M | 1M | −750,000 |
🔒 Free account: see all 9.
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q3 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Nov 16, 2026 | 13F-HR | Q3 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →BlackBarn Capital Partners 13F FAQ
What does BlackBarn Capital Partners own?
BlackBarn Capital Partners reported 18 stocks worth $510M in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are AZUL (30.6%), PRVA (9.4%) and ROIV (9.4%). The table above lists every position in the filing (the top 10 without an account).
What did BlackBarn Capital Partners buy and sell in Q3 2026?
Compared with Q2 2026: 5 new positions, 3 added to, 6 trimmed and 4 sold out. New positions include NXT, TMO and CSW. It sold all of NIQ, UNH and AMRX.
When will BlackBarn Capital Partners file its next 13F?
Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.
How much is BlackBarn Capital Partners's portfolio worth?
The Q3 2026 filing reports $510M in US stocks ($1.2B including options). That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.























